JCI - Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia

Jci_page_head_homepage_01

Jci_page_head_homepage_02

Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia

Brian J. Druker, Nicholas B. Lydon

Published in Volume 105, Issue 1

J Clin Invest. 2000; 105(1):3–7 doi:10.1172/JCI9083

This article Copyright © 2000, The American Society for Clinical Investigation

Full text | PDF

Options: View larger image (or click on image)

Medium

Table 1

Selected small-molecule ATP-competitive protein kinase inhibitors in development

Copyright © 2011 American Society for Clinical Investigation.
The JCI is the publication of the ASCI, an honor society of physician-scientists.
Copying, redistribution, and other usage policies